Skip to main content

BioDelivery Sciences ahead of schedule in developing neuropathy treatment

Raleigh drug developer BioDelivery Sciences International says it is ahead of schedule to test a proposed treatment for painful diabetic neuropathy (PDN)...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.